Terpigorev S A, Novikov A A, El-Zein B A, Aleksandrova E H, Iazdovskiĭ V V, Moskalets O V, Paleev F N
Ter Arkh. 2013;85(3):23-7.
To assess cytokine spectrum changes in different types of pulmonary sarcoidosis (PS).
Twenty-seven PS patients without signs of pulmonary fibrosis and 14 patients with sarcoidosis complicated by pulmonary fibrosis were examined. Baseline serum Th1 and Th2 cytokine concentrations were studied. A control group comprised 30 healthy donors.
A higher interleukin (IL)-4/IL-2 ratio was found in the peripheral blood of the patients with pulmonary fibrosis-complicated sarcoidosis than in the other patients (326.4 +/- 122.6 and 88.2 +/- 28.6%, respectively; p = 0.002). The sarcoidosis patients with signs of pulmonary fibrosis and no symptoms of disease inflammatory activity had elevated blood IL-1 levels whereas an IL-1 receptor antagonist was decreased.
In the patients with PS, the development and progression of pulmonary fibrosis occur with a shift in the Th1/Th2 balance towards Th2, which manifests itself as a higher IL-4/IL-2 ratio in the peripheral blood. At the same time, the signs of systemic inflammatory activity remain.
评估不同类型肺结节病(PS)中细胞因子谱的变化。
对27例无肺纤维化迹象的PS患者和14例合并肺纤维化的结节病患者进行检查。研究基线血清Th1和Th2细胞因子浓度。对照组包括30名健康供者。
合并肺纤维化的结节病患者外周血中白细胞介素(IL)-4/IL-2比值高于其他患者(分别为326.4±122.6和88.2±28.6%;p = 0.002)。有肺纤维化迹象且无疾病炎症活动症状的结节病患者血液中IL-1水平升高,而IL-1受体拮抗剂水平降低。
在PS患者中,肺纤维化的发生和进展伴随着Th1/Th2平衡向Th2偏移,这在外周血中表现为较高的IL-4/IL-2比值。同时,全身炎症活动的迹象仍然存在。